Pages that link to "Q80130214"

The following pages link to A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors (Q80130214):

Displaying 39 items.

• Advances in drug delivery system for platinum agents based combination therapy (Q26771390) (← links)
• Polymer-drug conjugates: origins, progress to date and future directions (Q27002505) (← links)
• The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs (Q28066801) (← links)
• Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics (Q30421664) (← links)
• Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts (Q33554366) (← links)
• HPMA copolymers: origins, early developments, present, and future (Q33719148) (← links)
• Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin (Q33962540) (← links)
• Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy (Q34005179) (← links)
• Macromolecular therapeutics (Q34079574) (← links)
• Nanocarriers for delivery of platinum anticancer drugs. (Q34338695) (← links)
• The resurgence of platinum-based cancer chemotherapy (Q34649255) (← links)
• Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents. (Q35009186) (← links)
• Polymeric conjugates for drug delivery (Q36029175) (← links)
• Cisplatin‐Loaded Porous Si Microparticles Capped by Electroless Deposition of Platinum (Q36039437) (← links)
• Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity (Q36094353) (← links)
• Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates (Q36204729) (← links)
• Hexanuclear self-assembled arene-ruthenium nano-prismatic cages: potential anticancer agents. (Q36232940) (← links)
• Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs (Q36502354) (← links)
• Polymer conjugates as anticancer nanomedicines (Q36561667) (← links)
• Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review) (Q36643541) (← links)
• Synthetic polymers as drug-delivery vehicles in medicine (Q36662516) (← links)
• Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer? (Q36691329) (← links)
• Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines. (Q36948510) (← links)
• Prodrug strategies in anticancer chemotherapy (Q36982570) (← links)
• Novel metals and metal complexes as platforms for cancer therapy (Q37137649) (← links)
• Metal-containing and related polymers for biomedical applications (Q37201391) (← links)
• Advances of cancer therapy by nanotechnology (Q37234202) (← links)
• Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate (Q37334071) (← links)
• Clinical developments in nanotechnology for cancer therapy (Q37765187) (← links)
• Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research. (Q37981001) (← links)
• Nanoparticle formulations of cisplatin for cancer therapy (Q38723829) (← links)
• The relevance of polar surface area (PSA) in rationalizing biological properties of several cis-diamminemalonatoplatinum(II) derivatives (Q39819988) (← links)
• Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes (Q41429967) (← links)
• Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems (Q42170543) (← links)
• The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment (Q48558433) (← links)
• The expanding role of prodrugs in contemporary drug design and development. (Q52560078) (← links)
• "Platinum on the road": Interactions of antitumoral cisplatin with proteins (Q59172548) (← links)
• Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice In Vivo (Q89736510) (← links)
• Targeted Delivery of Cisplatin-Derived Nanoprecursors via a Biomimetic Yeast Microcapsule for Tumor Therapy by the Oral Route (Q90533360) (← links)